Insulin Susp Isophane Beef
drugOn this page
Summary
Insulin Susp Isophane Beef (CHEMBL1201545) is an approved protein; indicated across 4 conditions including gestational diabetes and type 1 diabetes mellitus.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Protein
- Indications: 4 conditions
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201545 |
| Name | Insulin Susp Isophane Beef |
| Type | Protein |
| Max phase | 4 |
Also known as: Insulin susp isophane beef, INSULIN SUSP ISOPHANE BEEF
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
4 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| gestational diabetes | 3 | MONDO:0005406 | EFO:0004593 |
| type 1 diabetes mellitus | 3 | MONDO:0005147 | MONDO:0005147 |
| type 2 diabetes mellitus | 3 | MONDO:0005148 | MONDO:0005148 |
| diabetes mellitus | 3 | MONDO:0005015 | EFO:0000400 |
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).